104 related articles for article (PubMed ID: 11703592)
1. Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis.
Kasuga H; Ito Y; Sakamoto S; Kawachi H; Shimizu F; Yuzawa Y; Matsuo S
Kidney Int; 2001 Nov; 60(5):1745-55. PubMed ID: 11703592
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.
Kim HW; Kim BC; Song CY; Kim JH; Hong HK; Lee HS
Kidney Int; 2004 Nov; 66(5):1859-65. PubMed ID: 15496156
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2007 May; 71(9):882-8. PubMed ID: 17299519
[TBL] [Abstract][Full Text] [Related]
4. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
6. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
[TBL] [Abstract][Full Text] [Related]
7. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
8. Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.
Nakamuta M; Morizono S; Tsuruta S; Kohjima M; Kotoh K; Enjoji M
Int J Mol Med; 2005 Jul; 16(1):59-64. PubMed ID: 15942678
[TBL] [Abstract][Full Text] [Related]
9. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
[TBL] [Abstract][Full Text] [Related]
10. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
11. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
Kagami S; Border WA; Ruoslahti E; Noble NA
Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
[TBL] [Abstract][Full Text] [Related]
12. Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis.
Peters H; Border WA; Noble NA
Kidney Int; 2000 Mar; 57(3):992-1001. PubMed ID: 10720952
[TBL] [Abstract][Full Text] [Related]
13. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of glomerular extracellular matrix and transforming growth factor-beta expression in RF/J mice.
Kamata T; Muso E; Yashiro M; Kawamura T; Oyama A; Matsushima H; Takeuchi E; Yoshida H; Sasayama S
Kidney Int; 1999 Mar; 55(3):864-76. PubMed ID: 10027923
[TBL] [Abstract][Full Text] [Related]
15. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Mitani O; Katoh M; Shigematsu H
Pathol Int; 2004 Apr; 54(4):241-50. PubMed ID: 15028025
[TBL] [Abstract][Full Text] [Related]
16. Histological changes and immunohistochemical markers in the assessment of glomerulosclerosis in patients with glomerulonephritis.
Bob FR; Gluhovschi G; Herman D; Bozdog G; Gluhovschi C; Velciov S; Potencz E; Petrica L
Rom J Morphol Embryol; 2011; 52(3 Suppl):1027-32. PubMed ID: 22119820
[TBL] [Abstract][Full Text] [Related]
17. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
18. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K
Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors.
Rampino T; Gregorini M; Bedino G; Piotti G; Gabanti E; Ibatici A; Sessarego N; Piacenza C; Balenzano CT; Esposito P; Bosio F; Soccio G; Frassoni F; Dal Canton A
Clin Sci (Lond); 2011 Jan; 120(1):25-36. PubMed ID: 20583996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
